Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 197

1.
2.

Prevalence of and predictive factors for nonalcoholic fatty liver disease in Sudanese individuals with type 2 diabetes: Is metabolic syndrome the culprit?

Almobarak AO, Barakat S, Suliman EA, Elmadhoun WM, Mohamed NA, Abobaker IO, Noor SK, Bushara SO, Ahmed MH.

Arab J Gastroenterol. 2015 Jun;16(2):54-8. doi: 10.1016/j.ajg.2015.06.001. Epub 2015 Jul 11.

PMID:
26174761
3.

Nonalcoholic fatty liver disease is associated with low HDL cholesterol and coronary angioplasty in patients with type 2 diabetes.

Trojak A, Waluś-Miarka M, Woźniakiewicz E, Małecki MT, Idzior-Waluś B.

Med Sci Monit. 2013 Dec 16;19:1167-72. doi: 10.12659/MSM.889649.

4.

Anthropometric measures of visceral and subcutaneous fat are important in the determination of metabolic dysregulation in boys and girls at risk for nonalcoholic fatty liver disease.

Mager DR, Yap J, Rodriguez-Dimitrescu C, Mazurak V, Ball G, Gilmour S.

Nutr Clin Pract. 2013 Feb;28(1):101-11. doi: 10.1177/0884533612454884. Epub 2012 Oct 5.

PMID:
23042833
5.

Prevalence, risk factors, and predictors of nonalcoholic fatty liver disease among schoolchildren: a hospital-based study in Alexandria, Egypt.

Alkassabany YM, Farghaly AG, El-Ghitany EM.

Arab J Gastroenterol. 2014 Jun;15(2):76-81. doi: 10.1016/j.ajg.2014.05.002. Epub 2014 Jul 10.

PMID:
25097051
6.

Non alcoholic fatty liver disease in a Nigerian population with type II diabetes mellitus.

Olusanya TO, Lesi OA, Adeyomoye AA, Fasanmade OA.

Pan Afr Med J. 2016 May 6;24:20. doi: 10.11604/pamj.2016.24.20.8181. eCollection 2016.

7.

Prevalence of non-alcoholic fatty liver disease and its correlation with coronary risk factors in patients with type 2 diabetes.

Agarwal AK, Jain V, Singla S, Baruah BP, Arya V, Yadav R, Singh VP.

J Assoc Physicians India. 2011 Jun;59:351-4.

PMID:
21751587
8.

[Non-alcoholic fatty liver in children and adolescents with excess weight and obesity].

Guijarro de Armas MG, Monereo Megías S, Navea Aguilera C, Merino Viveros M, Vega Piñero MB.

Med Clin (Barc). 2015 Jan 20;144(2):55-8. doi: 10.1016/j.medcli.2014.02.018. Epub 2014 Apr 24. Spanish.

PMID:
24768200
9.

Nonalcoholic fatty liver disease and microvascular complications in type 2 diabetes.

Lv WS, Sun RX, Gao YY, Wen JP, Pan RF, Li L, Wang J, Xian YX, Cao CX, Zheng M.

World J Gastroenterol. 2013 May 28;19(20):3134-42. doi: 10.3748/wjg.v19.i20.3134.

10.

Association of adiponectin with hepatic steatosis: a study of 1,349 subjects in a random population sample.

Flechtner-Mors M, George SN, Oeztuerk S, Haenle MM, Koenig W, Imhof A, Boehm BO, Graeter T, Mason RA, Kratzer W, Akinli AS; EMIL-Study group.

BMC Res Notes. 2014 Apr 3;7:207. doi: 10.1186/1756-0500-7-207.

11.

Gender impacts on the correlations between nonalcoholic fatty liver disease and hypertension in a Chinese population aged 45-60 y.

Li XD, Qiu BH, Su FC, Sun SX.

Clin Exp Hypertens. 2016;38(7):639-643. Epub 2016 Sep 28.

PMID:
27680771
12.

Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta-analysis.

Ballestri S, Zona S, Targher G, Romagnoli D, Baldelli E, Nascimbeni F, Roverato A, Guaraldi G, Lonardo A.

J Gastroenterol Hepatol. 2016 May;31(5):936-44. doi: 10.1111/jgh.13264. Review.

PMID:
26667191
13.

Cardiovascular risk factors, nonalcoholic fatty liver disease, and carotid artery intima-media thickness in an adolescent population in southern Italy.

Caserta CA, Pendino GM, Amante A, Vacalebre C, Fiorillo MT, Surace P, Messineo A, Surace M, Alicante S, Cotichini R, Zuin M, Rosmini F, Mele A, Marcucci F.

Am J Epidemiol. 2010 Jun 1;171(11):1195-202. doi: 10.1093/aje/kwq073. Epub 2010 May 9.

14.

A vegetarian diet does not protect against nonalcoholic fatty liver disease (NAFLD): A cross-sectional study between Buddhist priests and the general population.

Choi SH, Oh DJ, Kwon KH, Lee JK, Koh MS, Lee JH, Kang HW.

Turk J Gastroenterol. 2015 Jul;26(4):336-43. doi: 10.5152/tjg.2015.0046. Epub 2015 Jun 2.

15.

Sex differences in the impact of nonalcoholic fatty liver disease on cardiovascular risk factors.

Du T, Sun X, Yuan G, Zhou X, Lu H, Lin X, Yu X.

Nutr Metab Cardiovasc Dis. 2017 Jan;27(1):63-69. doi: 10.1016/j.numecd.2016.10.004. Epub 2016 Oct 19.

PMID:
27956025
16.

[Risk factors associated with non-alcoholic fatty liver disease: a case-control study].

Caballería L, Arteaga I, Pera G, Rodríguez L, Alumà A, Auladell MA, Torán P.

Med Clin (Barc). 2013 Sep 21;141(6):233-9. doi: 10.1016/j.medcli.2012.11.034. Epub 2013 Apr 17. Spanish.

PMID:
23601740
17.

Carotid intima-media thickness and flow-mediated dilation in obese children with non-alcoholic fatty liver disease.

Torun E, Aydın S, Gökçe S, Özgen İT, Donmez T, Cesur Y.

Turk J Gastroenterol. 2014 Dec;25 Suppl 1:92-8. doi: 10.5152/tjg.2014.5552.

18.

Nonalcoholic fatty liver disease in morbidly obese subjects: correlation among histopathologic findings, biochemical features, and ultrasound evaluation.

Cazzo E, de Felice Gallo F, Pareja JC, Chaim EA.

Obes Surg. 2014 Apr;24(4):666-8. doi: 10.1007/s11695-014-1183-4.

PMID:
24415281
19.

[Determinants of nonalcoholic fatty liver disease in men and women with type 2 diabetes].

Trojak A, Idzior-Waluś B, Waluś-Miarka M, Małecki M.

Przegl Lek. 2014;71(12):677-80. Polish.

PMID:
25951695
20.

Relationship between obesity, metabolic syndrome, and nonalcoholic fatty liver disease in the elderly agricultural and fishing population of Taiwan.

Shen HC, Zhao ZH, Hu YC, Chen YF, Tung TH.

Clin Interv Aging. 2014 Mar 27;9:501-8. doi: 10.2147/CIA.S59538. eCollection 2014.

Supplemental Content

Support Center